MKS Inc. (MKSI)

Investment Review After Q1 FY2026 Earnings (2026.05.10)

TL;DR

MKS Inc. runs three distinct growth engines: semi tools/subsystems (43% revenue, WFE-cycle driven), advanced-PCB chemistry (30%, secular AI tailwind decoupled from WFE), and Specialty Industrial (27%, non-semi — CPO/defense/LEO satellites). Just reported revenue $1.08B (+15% YoY), Q2 guided $1.2B (+25%) at 47% GM. Stock up ~140% over 9 quarters ($131 → $313); the 54x P/E(ttm) prices in WFE up-cycle plus AI, with LT revenue growth ceiling ~15-20% blended across engines. Downside: Malaysia ramp execution and Specialty Industrial demand softness.

Summary

Finding	Assessment
9-Quarter Stock Return	$131→$313 (+139%). Trough $81 (Q1 2025) → +287% rebound. TTM OP +22% ($479M→$583M). P/E re-rated 24x→54x on AI + WFE up-cycle.
Business Model	Three growth engines: Semi tools/subsystems (43%, WFE-driven) + AI-PCB chemistry (30%, secular, ex-WFE) + Specialty Industrial (27%, non-semi: CPO/defense/LEO). $4.3B TTM, 47% non-GAAP GM.
Competitive Moat	NARROW Designed-in subsystems with long requalification cycles; unique chemistry + photonics scope. Coherent / AMAT / Element compete.
Past 5-YR Drivers	Atotech transformation (2022), WFE cycle trough-to-recovery, AI tailwind (HBM, CPO, advanced PCB), margin discipline holding GM 47% through trough.
Recent Stock Move	$81 trough (Q1 2025) → $313 (current). Q1 2026 +15% rev beat; Q2 +25% guide; 14% dividend raise.
Revenue Trend	ACCELERATING Rev YoY: 15% (Q1 2026) → 25% (Q2 2026E).
Margin Trend	EXPANDING OM%: 15% (Q1 2026) → 18% (Q2 2026E).
TTM OP Trajectory	ACCELERATING TTM OP QoQ: +11% (Q1 2026) → +14% (Q2 2026E). TTM OP $583M→$667M.
Key Opportunities	2027 WFE $170-180B ramp, AI E&P chemistry +22%, CPO/Newport ULTRAlign, Malaysia Super Center June 2026, Investor Day Dec 14, 2026.
Key Risks	54x P/E on trough earnings, Specialty Industrial -2% QoQ, leverage 3.5-4.4x EBITDA, WFE cycle delay risk.
Catalysts	Q2 2026 print, Malaysia Super Center opening Jun 2026, Investor Day Dec 14, 2026, 2027 WFE ramp confirmation.
P/E(ttm) Valuation	54x supported by 25%+ revenue growth and margin expansion. Upside 60-65x on 2027 visibility; downside 30-35x on WFE cycle delay.

Q1 FY2026 Key Data

Revenue $1,078M (+15% YoY, +4% QoQ) beat midpoint. Non-GAAP GM 47%, adj EBITDA $277M (25.7% margin), adj EPS $2.30. GAAP OI $149M (15.5% margin) per Excel.
By segment: Semiconductor $466M (+13% YoY, +7% QoQ); Electronics & Packaging $321M (+27% YoY, +6% QoQ — chemistry +22% YoY ex-FX); Specialty Industrial $291M (+8% YoY, -2% QoQ).
Q2 guided to $1.2B ±$40M revenue (+25% at midpoint), GM 47% ±100bps, adj EBITDA $328M ±$26M, adj EPS $2.90 ±$0.30. Dividend raised +14% to $0.25/share.

Key Takeaways from Earnings Call

WFE up-cycle is here and MKS has capacity ready. Management calls 2026 WFE ~$140B and is already ordering capacity for a 2027 ramp toward $170-180B. Malaysia “Super Center” opens June 2026 as the advanced-packaging hub. AI workloads drive deposition/etch intensity in DRAM and foundry plus NAND upgrades for inferencing storage.
Electronics & Packaging is the AI proxy — chemistry up 22% ex-FX. Advanced PCB layer counts and HVM substrates demand more chemistry. AI is ~15% of chemistry revenue, growing fast. CPO (co-packaged optics) momentum drives Newport ULTRAlign packaging revenue.
Specialty Industrial is the swing segment. Datacom CPO via Newport ULTRAlign and defense / LEO satellite tool-of-record for laser drilling are durable growth pockets. Industrial demand (medical, research) lagging — -2% QoQ but +8% YoY. Management expects flat-to-up sequential Q2.
Balance sheet still levered but improving. Net debt $3.6B at ~3.5x non-GAAP leverage (Excel Debt/EBITDA 4.4x GAAP). FCF $29M in Q1 (seasonally low). 14% dividend raise + ongoing deleveraging signal management confidence. Investor Day Dec 14, 2026 in NYC.

Key Segments and Revenue Mix (Q1 FY2026)

Segment	Q1 2026 Revenue	% of Total	Key Details
Semiconductor	$466M	43%	+13% YoY, +7% QoQ. Vacuum subsystems, RF power, photonics, lasers, ozone delivery for deposition/etch/litho. Customers: AMAT, LRCX, KLAC, TEL, ASML. AI-driven HBM/foundry/leading-edge logic intensity.
Electronics & Packaging	$321M	30%	+27% YoY, +6% QoQ. Chemistry +22% YoY ex-FX. Advanced PCB plating, substrates for HBM/CoWoS, IC interconnect chemistries. AI ~15% of segment revenue.
Specialty Industrial	$291M	27%	+8% YoY, -2% QoQ. Newport ULTRAlign packaging for CPO/datacom, lasers, medical, research, defense, LEO satellite laser-drilling tool of record.

Manufacturing footprint: Malaysia “Super Center” opens June 2026 as advanced-packaging hub; existing sites in US (Newport, RF, lasers), Germany (Atotech chemistry), Asia. Key competitors: Applied Materials (subsystems), Coherent (lasers), Atotech historical peers (chemistry), II-VI / Coherent (photonics), Element Solutions (specialty chemicals).

Business Model

SUPPLIERS

Specialty chemicals & metals (Cu, Ni, Au)
Optical components & laser diodes
Vacuum hardware & RF generators
Electronics & semis (controllers)

Components / Chemistries →

MKS INC.

Three growth engines:
1. Semi tools/subsystems (43%, WFE)
2. AI-PCB chemistry (30%, secular, ex-WFE)
3. Specialty Industrial (27%, non-semi)
$1.08B Q1'26 ($4.3B TTM) · LT ceiling ~15-20%

Subsystems / Process IP → $ Revenue

CUSTOMERS

Semi OEMs (AMAT, LRCX, KLAC, TEL, ASML)
PCB & substrate makers (TSMC, Unimicron)
HBM/foundry/IDMs (Samsung, SK Hynix, Intel)
Datacom, defense, medical, industrial

Moat Assessment: NARROW

Designed-in subsystems create switching cost: Vacuum, RF power, photonics, and lasers are spec’d into customer process tools. Once qualified, replacement requires re-qualification cycles measured in years. Tool-of-record positions in CPO laser drilling and Newport ULTRAlign are sticky.
Surround-the-Wafer scope unique post-Atotech: No other supplier combines vacuum/RF/photonics subsystems with advanced-packaging chemistries at this scale. Cross-sell opportunity to advanced packaging OEMs is real but execution-dependent and not yet fully captured.
Competitive pressure persists: Coherent and II-VI compete in photonics/lasers; Applied Materials and Lam vertically integrate some subsystems; chemistry has Element Solutions and DuPont. Moat is narrow because top semi OEMs are concentrated and hold pricing leverage.

Stock vs. Earnings — 5-Year Performance

Stock at $313, vs $131 (Q1 2024) and $81 trough (Q1 2025) — +287% from trough. Bottomed in 2024-2025 on slow WFE recovery and the Atotech-deal debt overhang; recovered on AI tailwind, GM expansion to 47%, and Q1 2026 +15% revenue acceleration.
TTM OP rose from $479M (Q1 2024) to $583M (Q1 2026) — +22%. The trough was Q4 2024 at $497M before the WFE up-cycle re-accelerated revenue. Q2 2026E TTM OP at $667M (+39% from trough).
P/E(ttm) expanded from 24x (Q1 2025 low) to 54x (Q2 2026E) as the market re-rated MKS toward an AI-infrastructure-supplier multiple. The 54x prints on a still-cyclically-trough EPS base — if 2027 WFE hits $170B, the forward multiple looks materially lower.

Past 5-Year Key Drivers

Atotech transformation completed (closed Aug 2022, $5.1B): Combined MKS’s subsystems (Semi + Newport photonics) with Atotech’s chemistry & equipment for advanced packaging. Created a unique “Surround the Wafer” strategy. Debt overhang dominated 2023-2024 narrative; 2026 marks deleveraging visibility with $0.25 dividend raise.
WFE cyclicality and recovery shape the stock: 2023-2024 WFE down-cycle plus Atotech debt drove stock from ~$170 to $81 trough. 2025-2026 recovery (WFE ~$140B 2026, $170-180B 2027) plus AI tailwind drove +287% rebound from the trough. P/E expanded 24x → 54x as visibility improved.
Margin and FCF discipline through the cycle: Non-GAAP GM held 46-47% even at trough revenue. TTM FCF/OP held 80-100% through 2025, dipping to 69% in Q1 2026 only because operating profit base expanded fast. R40 climbed from 3% (Q2 2024) to 31% (Q1 2026) and is guided to 43% in Q2 2026E.

Quarterly Key Metrics

USD	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26E
Quarter End	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Stock	$131	$129	$109	$103	$81	$100	$122	$162	$210	$313
Stock QoQ	+30%	-2%	-15%	-5%	-21%	+23%	+22%	+33%	+30%	+49%
Rev YoY	9%	-12%	-4%	5%	8%	10%	10%	11%	15%	25%
OM%	12%	14%	14%	15%	12%	14%	14%	14%	15%	18%
R40 (RevYoY+OM%)	22%	3%	10%	19%	20%	24%	24%	24%	31%	43%
TTM OP ($M)	$479	$459	$469	$497	$502	$510	$520	$527	$583	$667
TTM OP QoQ	+28%	-4%	+2%	+6%	+1%	+2%	+2%	+1%	+11%	+14%
FCF/OP	54%	94%	92%	82%	96%	103%	102%	94%	69%	69%
Debt/EBITDA	5.5x	5.8x	5.7x	5.3x	5.2x	5.1x	4.9x	4.8x	4.4x	4.4x
P/E(ttm)	61x	95x	64x	37x	24x	25x	30x	37x	43x	54x

Recent Stock Performance & Drivers

Stock currently $313, vs $81 (Q1 2025 trough) and $210 (Q1 2026 close). Driven by Q1 2026 +15% revenue, the Q2 +25% revenue guide, GM expansion to 47%, and the 14% dividend raise. AI-tailwind narrative (CPO, HBM, advanced PCB) lifted multiple from 24x to 54x.
TTM OP grew from $479M (Q1 2024) to $583M (Q1 2026, +22%); Q2 2026E guided to $667M (+39% off trough). FCF/OP dropped to 69% in Q1 only because Q1 is seasonally low on cash conversion — trailing pattern was 94-103% through 2025.
P/E(ttm) expanded from 24x to 54x, repricing MKS as an AI-infrastructure-supplier alongside Coherent, AMAT, and KLAC. The 54x prints on cyclically-trough earnings; if 2027 WFE materializes at $170-180B, forward multiple compresses materially even without further multiple expansion.

Opportunities

Engine #1 — Semi tools/subsystems on the WFE up-cycle (43% of revenue, cycle-driven): 2026 WFE ~$140B; 2027 step-up to $170-180B already in the order book. Q2 Semi guide $550M (+18% sequential). Malaysia Super Center opens Jun 2026 as the advanced-packaging hub for HBM/CoWoS.
Engine #2 — AI-PCB chemistry, secular and decoupled from WFE (30%): E&P chemistry +22% YoY ex-FX, AI ~15% of segment and growing. Advanced-PCB layer-count growth, HBM/CoWoS substrate plating, IC interconnect chemistries compound independently of wafer-start cycle. Q2 E&P guide $350M (+9% sequential).
Engine #3 — Specialty Industrial non-semi pockets (27%, fully outside semi cycle): Newport ULTRAlign tool-of-record for CPO datacom optics, laser drilling for defense and LEO satellites. Pure secular growth pool. Combined three engines support LT revenue growth ceiling ~15-20%.

Challenges

54x P/E on cyclically-trough earnings leaves no room for execution slips: A 2027 WFE-cycle delay (slower DRAM ramp, foundry capex push-out) would compress the multiple fast. Q2 guide implies 18% sequential Semi growth that requires Malaysia ramp on schedule. Any miss on the H2 2026 inflection narrative is a sharp downside risk.
Specialty Industrial -2% QoQ shows uneven non-AI demand: Medical, research, and industrial laser end-markets remain soft. Defense and LEO satellite are growing but small dollars. If these don’t inflect with the broader cycle, segment growth depends heavily on CPO datacom ramp — a concentration risk.
Leverage at 3.5-4.4x EBITDA still elevated: Even after deleveraging, balance sheet sensitivity to a cycle reversal is higher than peers. Interest expense remains a drag on net income. M&A capacity is constrained until net debt falls below 3x.

Next 12 Months

Q2 2026 guided $1.2B ±$40M revenue (+25%), 47% GM, adj EBITDA $328M ±$26M, EPS $2.90 ±$0.30. Sequential Semi $550M, E&P $350M, Specialty Industrial $300M. Implied Q3-Q4 trajectory remains in the WFE up-cycle on management commentary.
Malaysia Super Center opens June 2026: Advanced-packaging hub for HBM/CoWoS workflows. First-revenue contribution H2 2026; full ramp into 2027. Critical capacity addition for the WFE up-cycle.
Investor Day December 14, 2026 in NYC: Multi-year financial framework, capital allocation roadmap, segment LRP. Likely catalyst for further re-rating if management raises 2027-2028 revenue and OM targets.

Next 12-24 Months

2027 WFE ramp to $170-180B is the central thesis: Management already ordering long-lead capacity. If WFE materializes, MKS Semi segment could exceed $2.5B annual run-rate. Implied incremental margin 30%+ on volume leverage from existing footprint plus Malaysia.
CPO datacom inflection drives Specialty Industrial growth: Co-packaged optics moves from pilot to production at hyperscalers 2026-2027. Newport ULTRAlign tool-of-record position and laser drilling expertise create high-content opportunity. Could lift Specialty Industrial from $1.2B annual to $1.5B+ on CPO alone.
Advanced packaging chemistry compounds with HBM/CoWoS scale: Atotech’s chemistry portfolio is the unique under-appreciated asset. As substrate complexity (layer count, vias, copper plating sophistication) increases, dollar-per-substrate rises. Long-term margin expansion lever beyond the current 47% non-GAAP GM.

Core Metrics Scorecard

	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26E
Quarter End	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
R40 > 40%	✅				✅	✅		✅												✅
R40 accelerate					✅	✅		✅			✅		✅	✅	✅	✅	✅	✅	✅	✅
TTM OP QoQ > 10%											✅								✅	✅
TTM OP QoQ accelerate					✅	✅		✅			✅		✅	✅		✅	✅		✅	✅
TTM FCF/OP > 60%	✅	✅	✅		✅		✅			✅		✅	✅	✅	✅	✅	✅	✅	✅	✅
Debt/EBITDA < 3.5	✅	✅	✅	✅
Total passes	3	2	2	1	4	3	1	3	0	1	3	1	3	3	2	3	3	2	4	5
Stock QoQ	-15%	+16%	-10%	-34%	-17%	+0%	+3%	+22%	-18%	+19%	+30%	-2%	-15%	-5%	-21%	+23%	+22%	+33%	+30%	+49%
P/E(ttm)	16x	17x	15x	10x	11x	15x	31x	55x	45x	79x	61x	95x	64x	37x	24x	25x	30x	37x	43x	54x

MKSI’s scorecard inflected in Q1-Q2 2026 (4 then 5 passes) after years stuck at 1-3 through the WFE down-cycle. R40 finally crossed 40% (Q2 2026E at 43%), TTM OP QoQ > 10% returned (Q1 +11%, Q2 +14%), and FCF/OP held above 60%. Stock QoQ ran +30% / +49% over those two quarters, confirming the scorecard’s leading-indicator value.
Debt/EBITDA < 3.5 remains the only persistent fail: Despite deleveraging from 5.8x to 4.4x, MKS still trades structurally above the 3.5x threshold due to Atotech-deal debt. EBITDA growth through 2026-2027 is the path to passing this criterion, not aggressive paydown. A pass would unlock a 6-of-6 reading the market typically rewards with multiple expansion.

Chart: R40 vs Stock Price (Since 2020)

Chart: Scorecard Total Passes vs Stock Price (Since 2020)

Source: SEC EDGAR annual and quarterly filings, company earnings conference calls and presentations.

Disclaimer: This report is for educational purposes only. NO investment advice.